Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Specialty Sites
    • COVID-19
    • Practice Current
    • Practice Buzz
    • Without Borders
    • Equity, Diversity and Inclusion
    • Innovations in Care Delivery
  • Collections
    • Topics A-Z
    • Residents & Fellows
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Specialty Sites
    • COVID-19
    • Practice Current
    • Practice Buzz
    • Without Borders
    • Equity, Diversity and Inclusion
    • Innovations in Care Delivery
  • Collections
    • Topics A-Z
    • Residents & Fellows
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

Share

April 08, 2014; 82 (10 Supplement) April 29, 2014

Medical Marijuana Utilization and Perceived Therapeutic Value in Patients with ALS (P3.014)

Jacob Kaufman, Kelly Almasy, Ashley Boller, Nabila Dahodwala, Lauren Elman, Mary Kelley, Leo McCluskey
First published April 9, 2014,
Jacob Kaufman
3University of Pennsylvania Department of Neurology Philadelphia PA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kelly Almasy
4University of Pennsylvania School of Medicine Philadelphia PA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ashley Boller
4University of Pennsylvania School of Medicine Philadelphia PA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nabila Dahodwala
1Parkinson's disease and Movement Disorders Center Philadelphia PA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lauren Elman
2Penn Comprehensive Neuroscience Center Philadelphia PA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mary Kelley
4University of Pennsylvania School of Medicine Philadelphia PA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leo McCluskey
4University of Pennsylvania School of Medicine Philadelphia PA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Citation
Medical Marijuana Utilization and Perceived Therapeutic Value in Patients with ALS (P3.014)
Jacob Kaufman, Kelly Almasy, Ashley Boller, Nabila Dahodwala, Lauren Elman, Mary Kelley, Leo McCluskey
Neurology Apr 2014, 82 (10 Supplement) P3.014;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
0

Share

  • Article
  • Info & Disclosures
Loading

Abstract

OBJECTIVE: To investigate utilization and effectiveness of medical marijuana among a population of ALS patients, some of whom have legal access to marijuana and some of whom do not. BACKGROUND: Cannabis has immunomodulatory properties and effects upon excitotoxicity that suggest that it might have a disease-modifying role in ALS. There have also been some anecdotal reports suggesting that marijuana may be effective in alleviating certain ALS symptoms. Patients at the Penn ALS Center have been expressing increasing interest in learning about marijuana’s potential utility in managing their symptoms and their disease. DESIGN/METHODS: We conducted an anonymous survey of all ALS patients attending the Penn ALS Center from June 2013 to the present. Each patient was given a copy of the survey alone in their exam room. To preserve anonymity, patients were instructed not to include any identifiable information. The survey consisted of three yes/no questions and two Likert scale questions. RESULTS: The survey was given to 127 patients and 102 were completed (93% response rate). In total, 21% reported current or prior use of medical marijuana to treat their ALS symptoms. Of that 21%, large majorities considered it very effective in providing appetite stimulation (75%), aiding sleep (65%), relieving anxiety (80%), relieving depression (70%), and providing muscle relaxation (60%). 33% of the surveyed patients live in a state in which medical marijuana is legally available and, of that group, 18% have availed themselves of marijuana. Of the 66% without legal access, 81% reported interest in trying medical marijuana were it to be legalized. CONCLUSIONS: Those of our patients currently using marijuana report a very significant treatment effect on many ALS symptoms. Given the high degree of patient interest and reported therapeutic value, ALS clinicians should become better educated about the potential utility of marijuana in ALS symptom management.

Disclosure: Dr. Kaufman has nothing to disclose. Dr. Almasy has nothing to disclose. Dr. Boller has nothing to disclose. Dr. Dahodwala has received research support from Teva Neuroscience. Dr. Elman has nothing to disclose. Dr. Kelley has nothing to disclose. Dr. McCluskey has nothing to disclose.

Tuesday, April 29 2014, 3:00 pm-6:30 pm

  • Copyright © 2014 by AAN Enterprises, Inc.

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.

  • Stay timely. Submit only on articles published within the last 8 weeks.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • 200 words maximum.
  • 5 references maximum. Reference 1 must be the article on which you are commenting.
  • 5 authors maximum. Exception: replies can include all original authors of the article.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Disputes & Debates Submission Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
  • Info & Disclosures
Advertisement

Related Articles

  • No related articles found.

Alert Me

  • Alert me when eletters are published
Neurology: 96 (9)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2021 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise